Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism

Reduced therapeutic efficacy of sorafenib, a first-generation multikinase inhibitor, is often observed during the treatment of advanced hepatocellular carcinoma (HCC). Emodin is an active component of Chinese herbs, and is effective against leukemia, lung cancer, colon cancer, pancreatic cancer, and...

詳細記述

保存先:
書誌詳細
出版年:Int J Mol Sci
主要な著者: Kim, Young-Seon, Lee, Yoon-Mi, Oh, Taek-In, Shin, Dong Hoon, Kim, Geon-Hee, Kan, Sang-Yeon, Kang, Hyeji, Kim, Ji Hyung, Kim, Byeong Mo, Yim, Woo Jong, Lim, Ji-Hong
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213641/
https://ncbi.nlm.nih.gov/pubmed/30321984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19103127
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料